It’s all about the shoes…well, maybe not. Episode #356 by BMJ talk medicine published on 2018-11-16T13:30:55Z Minimalist? Maximalist? Zero drop? Is there really one running shoe paradigm to rule them all? On this week’s episode, Dr. Chris Napier PhD (T: @runnerphysio) and Paul Blazey (T: @Blazey85) joins BJSM’s Daniel Friedman (T:@ddfriedman) to debate running shoe prescription. Chris is a Clinical Assistant Professor in the Department of Physical Therapy at the University of British Columbia, where he recently obtained his his PhD (“Running biomechanics and injury prevention”) in 2018. Since becoming a physio, Chris has specialised his training with postgraduate studies in manual therapy and sport physiotherapy. He is currently a physiotherapist of Athletics Canada. Chris competed at the national level as a successful middle-distance runner and today is an avid skier, kayaker, and marathoner. A self-proclaimed encyclopaedia of running shoes, Paul is a physio who has spent time working with Crystal Palace and Arsenal FC, with a keen interest in managing running and triathlon injuries. He left his physiotherapy clinic in England behind in 2017 to take up research at the University of British Columbia and currently works as a senior associate editor for BJSM. Like Chris, Paul is an accomplished runner with envious marathon times. In this 20 minute conversation, Chris and Paul discuss: Eliud Kipchoge’s recent marathon world record Different running shoes’ effects on running economy Running shoe prescription and tips for choosing shoes in-store Gait retraining The future of running shoes Further reading: Brick NE, McElhinney MJ, Metcalfe RS. The effects of facial expression and relaxation cues on movement economy, physiological, and perceptual responses during running. Psychology of Sport and Exercise. 2018 Jan 1;34:20-8. https://www.sciencedirect.com/science/article/pii/S1469029217303461 Napier C, Willy RW. Logical fallacies in the running shoe debate: let the evidence guide prescription. https://bjsm.bmj.com/content/early/2018/10/22/bjsports-2018-100117 Hoogkamer W, Kram R, Arellano CJ. How biomechanical improvements in running economy could break the 2-hour marathon barrier. Sports Medicine. 2017 Sep 1;47(9):1739-50.https://link.springer.com/article/10.1007/s40279-017-0708-0 Barnes KR, Kilding AE. A Randomized Crossover Study Investigating the Running Economy of Highly-Trained Male and Female Distance Runners in Marathon Racing Shoes versus Track Spikes. Sports Medicine. 2018:1-2. https://link.springer.com/article/10.1007/s40279-018-1012-3 Nigg BM, Baltich J, Hoerzer S, Enders H. Running shoes and running injuries: mythbusting and a proposal for two new paradigms:‘preferred movement path’and ‘comfort filter’. Br J Sports Med. 2015 Jul 28:bjsports-2015. https://bjsm.bmj.com/content/49/20/1290.short Genre Science Comment by Rodger Kram A few notes: Hoogkamer et al. tested 14,16, 18 km/hr. Kipchoge ran slightly slower than 21km/hr (marathon is 42km). Kipchoge ran 2:04 in Berlin in Nike Streak 6 not Adidas boost, that was Kimetto. We don't yet know how much savings Kipchoge gets from the Vaporfly shoes, the average savings was 4% but some were 2 and some were 6. We have a new paper out on the biomechanics https://rdcu.be/bbOsv 2018-11-24T20:05:57Z